Studies will determine (1) ACTH response to thyrotropin-releasing hormone (TRH) in patients with presence or absence of pituitary macro- or adenoma, (2) whether serotoninergic pathways are involved in the response to these patients, and (3) if in normal subjects alterations in serotonergic pathways might induce an aberrant ACTH response to TRH.
Showing the most recent 10 out of 470 publications